Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Apr
29
2022
International Cooperation under China’s Proposed Implementing Rules for Human Genetic Resources Management Sheppard, Mullin, Richter & Hampton LLP
Apr
29
2022
How Pharmacies Can Defend Against PBM Audits Oberheiden P.C.
Apr
29
2022
New Guidance for Management of Biological Foodborne Outbreaks, and Identification of CCPs Keller and Heckman LLP
Apr
28
2022
FDA Updates FSVP Guidance on UFI Keller and Heckman LLP
Apr
28
2022
India: Another Booming Market for Alternative Proteins in Asia Keller and Heckman LLP
Apr
28
2022
The Metaverse: Alcohol Beverage Industry’s Next Marketing Frontier? ArentFox Schiff LLP
Apr
27
2022
Baby Food Lawsuit Dismissed as “Simply Speculative” Keller and Heckman LLP
Apr
27
2022
California Bill Proposes to Prohibit Employment Discrimination Against Marijuana Users Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
26
2022
Medicaid Best Price 101: A Review of Medicaid Best Price Policy and New CMS Guidance on Medicaid Best Price Reporting for Value Based Purchasing Arrangements Mintz
Apr
26
2022
What Municipalities Need to Know in 2022: Newly Signed Pennsylvania Legislation Strassburger McKenna Gutnick & Gefsky
Apr
26
2022
What’s Brewing at Starbucks? Labor Law Litigation Over Employee Terminations Barnes & Thornburg LLP
Apr
26
2022
FDA Urged to Make Changes to its Food Recall Activities Keller and Heckman LLP
Apr
25
2022
Morningstar Farms “Veggie” Product Labeling Complaint Dismissed Keller and Heckman LLP
Apr
25
2022
Navigating the Cannabis Fog: Litigation Ensues Over Legality of Delta-8 and Delta-10 Bradley Arant Boult Cummings LLP
Apr
25
2022
FDA Publishes Final Guidance for Industry on Drug Products, Including Biological Products, that Contain Nanomaterials Bergeson & Campbell, P.C.
Apr
22
2022
With Proposal to Cap Drug Price Increases, Massachusetts Once Again Takes Center Stage in the Drug Pricing Debate Mintz
Apr
22
2022
FDA Releases Draft Guidance on NAC Enforcement Keller and Heckman LLP
Apr
22
2022
Letter from the Editors: What a Long, Strange Trip It’s Been Bradley Arant Boult Cummings LLP
Apr
21
2022
Cannabis Goes to the Metaverse, Creating New Opportunities and Business Questions ArentFox Schiff LLP
Apr
21
2022
Don’t Tell Me This Town Ain’t Got No Heart: Mississippi’s Attorney General Opines on a City’s Ability to Regulate Medical Cannabis Businesses Bradley Arant Boult Cummings LLP
Apr
21
2022
CSPI Criticizes FDA Allergen Guidance Keller and Heckman LLP
Apr
21
2022
Insurance Coverage Considerations for Tribal Cannabis Businesses Van Ness Feldman LLP
Apr
21
2022
Uncertainty Abounds as EPA Works to Reach Any of The Destinations on Its PFAS Road Map but States Press On. Mintz
Apr
21
2022
TTB Issues Four-Part Series on Health-Related Alcohol Marketing Claims McDermott Will & Schulte LLP
Apr
21
2022
Whatever Happened to that Federal Contractor COVID Vaccine Order? Bradley Arant Boult Cummings LLP
Apr
20
2022
FDA Issues Draft Cybersecurity Guidance for Medical Devices Hunton Andrews Kurth
Apr
20
2022
California Federal Court Rules No Duty to Defend Opioid Lawsuits Wilson Elser Moskowitz Edelman & Dicker LLP
Apr
20
2022
FDA Amends Added Fluoride Levels in Bottled Water Keller and Heckman LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters